Elevated fat levels in your liver can raise your chances of developing serious health issues, including diabetes, ...

A 96-week clinical trial found that 300 mg of Vitamin E significantly improved liver histology and reduced inflammation in ...

Nonalcoholic fatty liver disease (NAFLD ... hypertension and hyperlipidemia. Nonalcoholic steatohepatitis (NASH) is the progressive form of liver injury that carries a risk for progressive ...

Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics ...

Nonalcoholic fatty liver disease (NAFLD) and its progressive form, nonalcoholic steatohepatitis (NASH) are the most common causes of chronic liver disease in industrialized countries. NAFLD has ...

Nearly 4 in 10 American adults are estimated to have a liver condition that can lead to serious complications and even death.

Whenever a story on fatty liver disease appears in the media, Columbia hepatologist Julia Wattacheril does what most people try to avoid: she reads ...

Non-alcoholic fatty liver disease (NAFLD ... but in some patients it progresses to non-alcoholic steatohepatitis (NASH). This Review discusses the link between metabolic dysfunction-associated ...

Altimmune's existence depends almost entirely on the outcome of the Phase 2 trial for pemvidutide in MASH. Learn why ALT ...

A new retrospective study found a significant association between lactate dehydrogenase (LDH) levels and the severity of ...

Metabolic dysfunction-associated steatohepatitis (MASH) significantly increases the risk of liver cirrhosis and ...